The effects of the thiolation with thioglycolic acid and L-cysteine on the mucoadhesion properties of the starch-graft-poly(acrylic acid)
dc.contributor.author | Gok, M. Koray | |
dc.contributor.author | Demir, Kamber | |
dc.contributor.author | Cevher, Erdal | |
dc.contributor.author | Ozsoy, Yildiz | |
dc.contributor.author | Cirit, Umut | |
dc.contributor.author | Bacinoglu, Suleyman | |
dc.contributor.author | Ozgumus, Saadet | |
dc.date.accessioned | 2024-04-24T16:11:00Z | |
dc.date.available | 2024-04-24T16:11:00Z | |
dc.date.issued | 2017 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | The aim of this study is to investigate the effects of the thiolation on the mucoadhesion characteristics of the gelatinized and crosslinked wheat starch-graft-poly(acrylic acid) [(WS-g-PAA)(gc)] for potential use in drug delivery via vaginal route. Thiolation of (WS-g-PAA)(gc) was first time realized using L-cysteine hydrochloride monohydrate (CyS) and thioglycolic acid (TGA). These conjugates [(WS-g-PAA)(gcth)] were characterized using FTIR. The free SH group, mucoadhesion, cytotoxicity characteristics and the mechanism of the thiolation were also evaluated. To obtain fundamental data for possible application such as drug carrier, in vitro and in vivo progesterone release profiles from the mucoadhesive tablet formulations were also determined. The results showed that, vaginal tablet containing (WS-g-PAA)(gc)-TGA, which has not contain free SH groups in its structure, displays higher mucoadhesion than (WS-g-PAA)(gc) and (WS-g-PAA)(gc)-CyS. This tablet formulation can also be used as a drug carrier in vaginal applications. (C) 2017 Elsevier Ltd. All rights reserved. | en_US |
dc.description.sponsorship | Scientific Research Projects Coordination Unit of Istanbul University [594/15122006, UDP-51789, BEK-21309, 8585] | en_US |
dc.description.sponsorship | This work was supported by Scientific Research Projects Coordination Unit of Istanbul University, Project Number 594/15122006, UDP-51789, BEK-21309 and 8585. Tablet formulation which was developed patented by the Turkish Patent Institute (TR 2012 03191 B, May 2015) and to be a patent applied the European Patent Office (19.03.2013-EP13160042.1). We would like to thank Institute of Aziz Sancar Experimental Medicine of Istanbul University for help in cytotoxicity assays. | en_US |
dc.identifier.doi | 10.1016/j.carbpol.2017.01.065 | |
dc.identifier.endpage | 136 | en_US |
dc.identifier.issn | 0144-8617 | |
dc.identifier.issn | 1879-1344 | |
dc.identifier.pmid | 28267489 | |
dc.identifier.scopus | 2-s2.0-85010377746 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 129 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.carbpol.2017.01.065 | |
dc.identifier.uri | https://hdl.handle.net/11468/15222 | |
dc.identifier.volume | 163 | en_US |
dc.identifier.wos | WOS:000396955500015 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Sci Ltd | en_US |
dc.relation.ispartof | Carbohydrate Polymers | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Mucoadhesion | en_US |
dc.subject | Starch | en_US |
dc.subject | Thiolation | en_US |
dc.subject | Thioglycolic Acid | en_US |
dc.subject | L-Cysteine | en_US |
dc.subject | Vaginal Tablet | en_US |
dc.title | The effects of the thiolation with thioglycolic acid and L-cysteine on the mucoadhesion properties of the starch-graft-poly(acrylic acid) | en_US |
dc.title | The effects of the thiolation with thioglycolic acid and L-cysteine on the mucoadhesion properties of the starch-graft-poly(acrylic acid) | |
dc.type | Article | en_US |